Mindray Medical (MR) Reports Q3 Adj-EPS of $0.33, Beats by 6c
More News related to MR
- Goldman Sachs Upgraded Mindray Medical (MR) to Conviction Buy
- Mindray to Hold Annual General Meeting in Hong Kong on December 15, 2009
- Mindray Medical to Exhibit at RSNA 2009 in Chicago, from November 29th to December 4th, 2009
- 2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer
- Mindray Medical (MR) Posts Q3 EPS of $0.38, Tops by 11c
More News related to Earnings
- Sidoti & Co Initiates Coverage on Cytec Industries (CYT) with a Neutral
- Sidoti & Co Initiates Coverage on Gammon Gold (GRS) with a Neutral
- ThinkEquity Initiates Coverage on Curis (CRIS) with a Buy
- Raymond James Initiates Coverage on Simmons First National (SFNC) with an Outperform
- JMP Starts Investment Service Stocks: BLK, FII at Outperform, LM, BEN, JNS, TROW at Market Perform
Mindray Medical International LTD (NYSE: MR) reports Q3 EPS of $0.33, ex-items, 6 cents better than the analyst estimate of $0.27.
Related Categories
EarningsStocks Mentioned
+0.09Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
